Akebia Therapeutics, Inc. (AKBA)
0.8925
-0.12
(-11.63%)
USD |
NASDAQ |
May 19, 16:00
0.8925
0.00 (0.00%)
After-Hours: 16:27
Akebia Therapeutics Research and Development Expense (Quarterly) : 14.48M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 210.17M |
| MannKind Corp. | 17.23M |
| United Therapeutics Corp. | 138.20M |
| Ardelyx, Inc. | 19.27M |
| Rhythm Pharmaceuticals, Inc. | 41.67M |